Mingjing Zhao Selected Research

Myocardial Infarction

1/2023	Bioinformatics prediction and experimental verification of a novel microRNA for myocardial fibrosis after myocardial infarction in rats.
1/2022	Effect of WenXin KeLi on Improvement of Arrhythmia after Myocardial Infarction by Intervening PI3K-AKT-mTOR Autophagy Pathway.
1/2021	Comparison of the Clinical Value of miRNAs and Conventional Biomarkers in AMI: A Systematic Review.
1/2021	Wenxin Granules Regulate Endoplasmic Reticulum Stress Unfolded Protein Response and Improve Ventricular Remodeling on Rats with Myocardial Infarction.
1/2021	Advances of Traditional Chinese Medicine Regulating Connexin43 in the Prevention and Treatment of Myocardial Infarction.
10/2020	Discovery of Natural Compounds for Cardiac Fibrosis by a Transcriptome-Based Functional Gene Module Reference Approach.
1/2020	Qiliqiangxin Capsules Optimize Cardiac Metabolism Flexibility in Rats With Heart Failure After Myocardial Infarction.
1/2020	Functional Gene Module-Based Identification of Phillyrin as an Anticardiac Fibrosis Agent.
1/2019	Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats.
1/2019	Wenxin Granules Influence the TGFβ-P38/JNK MAPK Signaling Pathway and Attenuate the Collagen Deposition in the Left Ventricle of Myocardial Infarction Rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mingjing Zhao Research Topics

Disease

17	Myocardial Infarction 01/2023 - 04/2011
9	Heart Failure 01/2024 - 01/2013
9	Inflammation (Inflammations) 12/2023 - 01/2015
6	Fibrosis (Cirrhosis) 12/2023 - 01/2018
4	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2017
3	Cognitive Dysfunction 01/2024 - 01/2021
3	Ventricular Remodeling 01/2021 - 01/2013
3	Lung Neoplasms (Lung Cancer) 12/2019 - 01/2013
2	Diabetes Mellitus 01/2023 - 01/2021
2	Infarction (Infarctions) 01/2023 - 06/2012
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 03/2019
2	Wounds and Injuries (Trauma) 01/2022 - 01/2020
2	Heart Diseases (Heart Disease) 01/2020 - 01/2020
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 04/2011
2	Atherosclerosis 01/2020 - 06/2002
2	Neoplasms (Cancer) 12/2019 - 09/2012
1	Dementia (Dementias) 12/2023
1	Stroke (Strokes) 12/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Acute Coronary Syndrome 01/2022
1	Atrophy 01/2021
1	Anemia 01/2021
1	Atrial Remodeling 01/2021
1	Ventricular Fibrillation 01/2021
1	Atrial Fibrillation 01/2021
1	Sleep Wake Disorders 01/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 11/2020
1	Pulmonary Arterial Hypertension 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Back Pain (Backache) 01/2020
1	Fatigue 01/2020
1	Pain (Aches) 01/2020
1	Ankylosing Spondylitis 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019
1	Respiratory Tract Diseases (Respiratory Tract Disease) 04/2019
1	Cicatrix (Scar) 01/2019
1	Vascular Remodeling 01/2015
1	Hyperplasia 01/2015
1	Carotid Artery Injuries 01/2015
1	Cardiomegaly (Heart Hypertrophy) 01/2013
1	Carcinogenesis 09/2012

Drug/Important Bio-Agent (IBA)

6	wenxin keliIBA 01/2022 - 01/2013
4	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2020
4	qiliqiangxinIBA 01/2020 - 01/2018
4	Capsules (Microcapsules)IBA 01/2020 - 01/2015
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2024 - 01/2022
3	salicylhydroxamic acid (SHAM)IBA 01/2023 - 01/2013
3	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2017
3	Connexin 43 (Connexin43)IBA 01/2022 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2012
3	CollagenIBA 01/2020 - 01/2015
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2021
2	C-Reactive ProteinIBA 01/2022 - 01/2020
2	Xue-Fu-Zhu-Yu decoctionIBA 01/2022 - 03/2019
2	ConnexinsIBA 01/2021 - 01/2015
2	LipidsIBA 01/2021 - 01/2020
2	Therapeutic UsesIBA 01/2020 - 01/2019
2	qiangxinIBA 01/2015 - 01/2015
1	Amino Acids FDA Link 01/2024
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2023
1	MB Form Creatine KinaseIBA 01/2022
1	Autophagy-Related ProteinsIBA 01/2022
1	Troponin IIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	Superoxide DismutaseIBA 01/2022
1	Nonprescription Drugs (Patent Medicines)IBA 01/2022
1	AntioxidantsIBA 01/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	CholesterolIBA 11/2020
1	schizandrer AIBA 10/2020
1	guanxin shutongIBA 01/2020
1	phillyrinIBA 01/2020
1	Apolipoproteins E (ApoE)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 12/2019
1	Small Nucleolar RNA (snoRNA)IBA 12/2019
1	Long Noncoding RNAIBA 12/2019
1	VimentinIBA 12/2019
1	Cadherins (E-Cadherin)IBA 12/2019
1	AntigensIBA 04/2019
1	Collagen Type I (Type I Collagen)IBA 01/2019
1	CytokinesIBA 01/2019
1	Translationally-Controlled 1 Tumor ProteinIBA 01/2018
1	Taohong Siwu decoction IIIBA 01/2018
1	CalciumIBA 01/2013
1	integrin-linked kinaseIBA 01/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2013
1	Messenger RNA (mRNA)IBA 09/2012
1	Amiodarone (Amiodarona)FDA LinkGeneric 06/2012
1	diallyl trisulfideIBA 06/2012
1	Vasodilator Agents (Vasodilators)IBA 04/2011
1	Arginine (L-Arginine)FDA Link 04/2011

Therapy/Procedure

8	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2015
5	Ligation 01/2023 - 01/2017
5	Therapeutics 01/2020 - 01/2018
1	Traction 12/2023
1	Complementary Therapies (Alternative Medicine) 01/2017